News Edwards Lifesciences Corporation

Equities

EW

US28176E1082

Real-time Estimate Cboe BZX Other stock markets 10:42:36 2024-05-06 am EDT			5-day change	1st Jan Change
85.36 ^USD	+0.13%		-0.63%	+12.01%

May. 01	Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing	MT
Apr. 30	Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing	May. 01	MT
Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing	Apr. 30	MT
Bernstein Adjusts Price Target on Edwards Lifesciences to $73 From $72	Apr. 29	MT
Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92	Apr. 26	MT
Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $83	Apr. 26	MT
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $99 From $94	Apr. 26	MT
UBS Adjusts Edwards Lifesciences Price Target to $95 From $92, Maintains Neutral Rating	Apr. 26	MT
Piper Sandler Adjusts Price Target on Edwards Lifesciences to $88 From $85	Apr. 26	MT
Canaccord Genuity Trims Price Target on Edwards Lifesciences to $85 From $86	Apr. 26	MT
Well, it isn't as bad as feared...	Apr. 26
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength	Apr. 25	RE
Transcript : Edwards Lifesciences Corporation, Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
Edwards Lifesciences Q1 Adjusted Earnings, Net Sales Increase, Q2 Guidance Set	Apr. 25	MT
Earnings Flash (EW) EDWARDS LIFESCIENCES CORPORATION Posts Q1 EPS $0.66, vs. Street Est of $0.64	Apr. 25	MT
Earnings Flash (EW) EDWARDS LIFESCIENCES CORPORATION Reports Q1 Revenue $1.6B, vs. Street Est of $1.57B	Apr. 25	MT
Edwards Lifesciences: Q1 Earnings Snapshot	Apr. 25	AQ
Edwards Lifesciences Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Edwards Lifesciences Reports First Quarter Results	Apr. 25	BU
Edwards Lifesciences Corporation Revises Earnings Guidance for the Full Year 2024	Apr. 25	CI
Edwards Lifesciences Corporation Provides Earnings Guidance for the Second Quarter of 2024	Apr. 25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 11:25 am EDT